• Citer

Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study

par Kristeleit, Rebecca;Leary, Alexandra;Delord, Jean Pierre;Moreno, Victor;Oaknin, Ana;Castellano, Daniel;Shappiro, Geoffrey G.I.;Fernández, Cristian;Kahatt, Carmen;Alfaro, Vicente;Siguero, Mariano;Rueda, Daniel;Zeaiter, Ali;Awada, Ahmad ;Santaballa, Ana;Zaman, Khalil;Sehouli, Jalid;Subbiah, Vivek
Référence Investigational new drugs, 41, 5, page (677-687)
Publication Publié, 2023-10

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study
Auteur:	Kristeleit, Rebecca; Leary, Alexandra; Delord, Jean Pierre; Moreno, Victor; Oaknin, Ana; Castellano, Daniel; Shappiro, Geoffrey G.I.; Fernández, Cristian; Kahatt, Carmen; Alfaro, Vicente; Siguero, Mariano; Rueda, Daniel; Zeaiter, Ali; Awada, Ahmad; Santaballa, Ana; Zaman, Khalil; Sehouli, Jalid; Subbiah, Vivek
Informations sur la publication:	Investigational new drugs, 41, 5, page (677-687)
Statut de publication:	Publié, 2023-10
Sujet CREF:	Pharmacologie
	Cancérologie
Mots-clés:	Endometrial cancer
	Lurbinectedin
	Phase 2
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0167-6997
	info:doi/10.1007/s10637-023-01383-2
	info:scp/85167334741
	info:pmid/37556023